nForm Blog
Category: Neuroscience
Autoimmunity Digital Spatial Profiling Neuroscience Oncology
Readers’ Favorite Webinars: A Year in Review
NanoString webinars allow you to sit back, relax and listen to a leader in the field talk about his/her research and/or answer your questions. They have always been a crowd-pleaser,…
Neuroscience
Of Inflammasome and Tauopathies in Mice and Men
Tauopathies are a class of neurodegenerative diseases characterized by the aggregation of tau proteins in neurofibrillary tangles in the human brain. These proteins are associated to microtubules and are found…
Autoimmunity Events Neuroscience Oncology Publication Watch
Top 5 Blog Posts of 2019
Last year marked remarkable progress for our customers, with hundreds of scientists making exceptional strides in their fields thanks to NanoString® technologies. 2019 saw the commercial launch of the GeoMx™…
Events Neuroscience
NanoString is headed to the Windy City for SfN!
Committed to accelerating transformative scientific discoveries, NanoString continues to develop and deliver cutting-edge molecular tools, carefully tailoring the designs to fit the specific needs of each research field and focus…
Neuroscience
A Strategic Attack Against Neurological Diseases
Neurological diseases are often multifactorial, brought on by a genetic and environmental tug-of-war and resulting in multifaceted clinical presentations. Such etiological complexity has hindered treatment progress and has necessitated well-thought-out…
Neuroscience
A Systematic Evaluation of Immune Response and Plaque Microenvironment Variation in Alzheimer’s Disease
Alzheimer’s disease (AD) – the most prevalent form of dementia – is associated with defining histopathological features that include amyloid-beta (Aβ) plaque deposition and tau protein aggregation, accompanied by synaptic…
Neuroscience
New Biology-Driven Drug Discoveries Needed for Treating of Alzheimer’s
Alzheimer’s disease (AD) is a slowly progressing neurodegenerative disorder that affects millions of people worldwide, leaving behind an immense psychological, emotional, and financial burden on patients, caregivers, and healthcare systems.…
Neuroscience
Q&A with Dr. Gregory Carter: Developing Computational Strategies and the MODEL-AD Consortium
Gregory Carter, Ph.D., is an Associate Professor at The Jackson Laboratory. His work is focused on developing computational strategies using genetic data to understand complex genetic systems. We recently spoke…
Neuroscience
Meta-analysis of AMP-AD Datasets Defines the Transcriptional Landscape of Alzheimer’s Disease
The Accelerating Medicines Partnership – Alzheimer’s Disease (AMP-AD) Consortium was formed to accelerate the development of diagnostics and therapeutics for this devastating and complex disease. One roadblock to development is…
Digital Spatial Profiling Neuroscience Q&A
Q&A with Dr. Stefan Prokop – Alzheimer’s: From the Amyloid Hypothesis to the Cellular Phase and Beyond
Stefan Prokop, MD, is a Neuropathologist and Research Fellow at the University of Pennsylvania School of Medicine. His work is focused on Alzheimer’s Disease (AD) with a specific interest in…
Neuroscience
Researcher Profiles: How NanoString® Neuroscience Grant Program Winners are Utilizing nCounter® Technology
Earlier this year, five neuro grant program applicants were awarded nCounter® Neuropathology or Neuroinflammation Panels to profile 24 samples. Applications spanned a wide range of disease specific applications with the…
Neuroscience Q&A
Rediscovering Microglia: Dr. Oleg Butovsky Discusses the Untapped Potential of Microglia in Neurodegenerative Diseases
Oleg Butovsky, Ph.D., is an Assistant Professor of Neurology at Harvard Medical School. His laboratory at the Center of Neurologic Diseases in Brigham & Women’s Hospital focuses on the basic…